Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Floats 'Bold' Value-Based Reimbursement Idea In Migraine

Nov 13 2017

• By Jessica Merrill

Human brain illustrated with millions of small nerves - Conceptual 3d render

Related Content

Novartis On Payer Contracts, Other Updates From BIO CEO & Investor Conference

Feb 15 2016

Novartis's Entresto Voyage: Hindsight Is 20/20

May 15 2017

Novartis Back In AMD Game With ‘Potential Blockbuster’ Brolucizumab

Nov 12 2017

Lilly Breathing Down Amgen/Novartis's Necks With Three Phase III Migraine Wins

May 12 2017

Novartis Aims Canakinumab At Targeted CV Patients

Nov 13 2017

Related Companies

Novartis AG

Amgen, Inc.

Eli Lilly and Company

Teva Pharmaceutical Industries Ltd.

Allergan plc

Additional Topics

Reimbursement Market Access Pricing Strategies Commercial Neurology BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window